HerAnova™ is providing non-invasive diagnostics and treatments designed to meet critical needs in endometriosis and infertility to improve women’s health.
HerAnova™ is providing non-invasive diagnostics and treatments designed to improve women’s health and meet critical needs in endometriosis and infertility.
“In fertility care, timing matters, HerResolve™ helps us personalize fertility plans for patients by identifying which
patients may need further evaluation and therapy before proceeding with fertility procedures.
That clarity is especially valuable when counseling patients who are already navigating an
emotional and time-sensitive fertility journey, providing added confidence at critical decision
points.”
“HerResolve™ helps us evaluate patients with suspected endometriosis using a non-invasive
approach, it supports clinical decision-making by helping align
surgical planning and fertility treatment timing, with the goal of preparing patients as effectively
as possible before IVF.”
Previous
Next
our areas of focus
Endometriosis
Endometriosis affects up to 10% of women of reproductive age.¹ We are developing a suite of breakthrough tests including HerResolveTM, a non-invasive blood-based test for the detection and confirmation of endometriosis.
Globally, 17.5% of the adult population suffers from infertility.² In the United States, 11% of women³ of reproductive age have experienced fertility problems. HerAnova is developing tests and treatments that can improve women’s chances of successfully achieving pregnancy.